Aster DM Healthcare acquired 4,50,89,995 equity shares in its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, for a total cash consideration of ₹45,08,99,950 on June 18, 2026. The acquisition, executed through a rights issue at ₹10 per share, consolidates 100% ownership of the Sarjapur Entity. The investment is intended for general corporate purposes of the subsidiary, which operates within the healthcare services sector.

The Sarjapur Entity was incorporated on July 21, 2025, in Bengaluru, Karnataka, with the objective of setting up and operating healthcare services. As the entity is yet to commence business, turnover figures are not applicable. The authorized share capital stands at ₹153,55,00,000, comprising equity shares and compulsorily convertible preference shares, while the paid-up share capital prior to this transaction was ₹50,10,00,000.

The transaction falls within the ambit of related party transactions as the Sarjapur Entity is a wholly owned subsidiary of Aster DM Healthcare. However, the deal is exempt from related party transaction provisions under Regulation 23(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as it involves a holding company and its wholly owned subsidiary. The transaction was conducted at an arm’s length basis.

No governmental or regulatory approvals were required for the acquisition. The allotment of the 4,50,89,995 equity shares was completed on June 18, 2026. Apart from the holding company, the promoter or promoter group companies do not hold any interest in the Sarjapur Entity.

Details of Acquisition

Aster DM Multispecialty Hospital Private Limited (ADMPL), a subsidiary of aster dm healthcare , has allotted 39,80,000 Compulsorily Convertible Preference Shares (CCPS) to identified investors on a preferential basis by way of private placement. The allotment was approved by ADMPL's board on June 16, 2026, pursuant to Regulation 30(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The issuance comprises both fully paid-up and partly paid-up shares, with a conversion ratio of up to 5 equity shares of ADMPL for each CCPS.

Breakdown of Allotment

The board allotted two distinct series of CCPS. Series A shares are fully paid-up, while Series B shares are partly paid-up. Both series carry a face value of Rs. 50 each.

Conversion and Shareholding Structure

The CCPS issued will convert into equity shares of ADMPL. As on the date of allotment, the conversion ratio stipulates that each CCPS shall convert into a maximum of up to 5 equity shares of ADMPL. This conversion mechanism will dilute the shareholding of existing stakeholders, subject to the terms approved by ADMPL shareholders.

Aster DM Healthcare disclosed that its shareholding in ADMPL will not go below 75% of the share capital on an as-if converted basis. This threshold accounts for the conversion of the allotted Series A CCPS, Series B CCPS, and any Additional Investment that ADMPL may finalize in the future.

Future Capital Raising Plans

ADMPL is actively pursuing further capital infusion. The subsidiary is in the process of finalizing other investors to whom certain other CCPS may be issued in due course. This prospective issuance is referred to as Additional Investment. The company confirmed that the 75% minimum shareholding commitment for Aster DM Healthcare remains valid even after this Additional Investment is accounted for.

The filing was submitted by Hemish Purushottam, Company Secretary and Compliance Officer of Aster DM Healthcare Limited.